# ğŸ§¬ MSK2025 í•™íšŒ ì¢…í•© ê°€ì´ë“œ | ë© ê³µìœ ìš©

**ëŒ€í•œë¯¼êµ­ ë¯¸ìƒë¬¼í•™íšŒ 2025 êµ­ì œí•™ìˆ ëŒ€íšŒ**
**ì¼ì‹œ**: 2025ë…„ 10ì›” 26-28ì¼ (ì¼-í™”)
**ì¥ì†Œ**: ëŒ€ì „ì»¨ë²¤ì…˜ì„¼í„°

---

## ğŸ“Œ ì´ ê°€ì´ë“œëŠ”?

MSK2025ì˜ **21ê°œ ì‹¬í¬ì§€ì—„, 4ê°œ ì›Œí¬ìƒµ, 4ê°œ ëŒ€í•™ì›ìƒ í¬ëŸ¼**ì„ **ì—°ìì™€ ë°œí‘œ ì œëª© ê¸°ë°˜ìœ¼ë¡œ ì‹¬ì¸µ ë¶„ì„**í•˜ì—¬, ë© êµ¬ì„±ì›ë“¤ì´ **ê°ìì˜ ì—°êµ¬ ë¶„ì•¼ì— ë§ê²Œ ì„¸ì…˜ì„ ì„ íƒ**í•  ìˆ˜ ìˆë„ë¡ ë•ëŠ” ì¢…í•© ê°€ì´ë“œì…ë‹ˆë‹¤.

### íƒ€ê²Ÿ ë…ì
- ì„¸ê· í•™, ë°”ì´ëŸ¬ìŠ¤í•™, ì§„ê· í•™, í™˜ê²½ ë¯¸ìƒë¬¼í•™, ìƒëª…ê³µí•™, ë°±ì‹ í•™ ë“± **ë‹¤ì–‘í•œ ë¶„ì•¼**
- ëŒ€í•™ì›ìƒ ~ PIê¸‰
- ë°”ì´ì˜¤ì¸í¬ë§¤í‹±ìŠ¤ ì „ê³µ / ë¹„ì „ê³µ ëª¨ë‘

### ì„ íƒ ê¸°ì¤€ (MECE)
```
ì—°êµ¬ ë¶„ì•¼ë³„
â”œâ”€ ë³‘ì›ì„± ë¯¸ìƒë¬¼ (Pathogenesis)
â”‚  â”œâ”€ ì„¸ê·  (S1, S4, S8)
â”‚  â”œâ”€ ë°”ì´ëŸ¬ìŠ¤ (S7, S16, S17)
â”‚  â””â”€ ì§„ê·  (S5)
â”œâ”€ í™˜ê²½/ì‘ìš© ë¯¸ìƒë¬¼ (Environment & Application)
â”‚  â”œâ”€ ë§ˆì´í¬ë¡œë°”ì´ì˜´ (S2, S9, S11, S15)
â”‚  â”œâ”€ í™˜ê²½ ë¯¸ìƒë¬¼ (S10, S12)
â”‚  â””â”€ í•©ì„±ìƒë¬¼í•™ (S18, S21)
â”œâ”€ ê¸°ë²•/ë°©ë²•ë¡  (Methodology)
â”‚  â”œâ”€ ì˜¤ë¯¹ìŠ¤ (S13, S14)
â”‚  â”œâ”€ ì§„ë‹¨ (S8)
â”‚  â””â”€ ì›Œí¬ìƒµ (W1-W5)
â””â”€ ê³µì¤‘ë³´ê±´/ë°±ì‹  (Public Health)
   â”œâ”€ ë°±ì‹  (S7, S16, S20)
   â”œâ”€ One Health (S17, S20)
   â””â”€ ìƒë¬¼ì•ˆì „ (S19)
```

---

# ğŸ“… ì‹œê°„ëŒ€ë³„ ì„¸ì…˜ ì„ íƒ ê°€ì´ë“œ

## Day 1: 10ì›” 26ì¼ (ì¼ìš”ì¼)

### â° 13:30-15:30 | ì²« ë²ˆì§¸ ì„¸ì…˜

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S1: Bacterial Pathogenesis</b> ğŸ¦ </td>
<td>ì„¸ê· í•™</td>
<td>ì„¸ê·  ë³‘ì›ì„±, ë…ì†Œ, AMR ì—°êµ¬ì</td>
<td>
<b>ë°œí‘œ 1: Byoung Sik Kim (Sogang)</b><br>
â€¢ <i>Vibrio vulnificus</i> MARTX ë…ì†Œ<br>
â€¢ Cell blebbing vs. effector translocation ë¶„ë¦¬<br>
â€¢ 2025ë…„ ìµœì‹ : N-glycan ê²°í•© ë©”ì»¤ë‹ˆì¦˜<br><br>

<b>ë°œí‘œ 2: Zhenbo Xu (South China Univ)</b><br>
â€¢ VBNC (Viable But Non-Culturable) ìƒíƒœ<br>
â€¢ ë°°ì–‘ ë¶ˆê°€ëŠ¥ ì„¸ê· ì˜ ìƒì¡´ ì „ëµ<br>
â€¢ í™˜ê²½ persistence, AMR ê´€ë ¨<br><br>

<b>ë°œí‘œ 3: Tao Dong (SUSTech)</b><br>
â€¢ Type VI Secretion System (T6SS) ì¡°ë¦½<br>
â€¢ <b>Phase separation</b> ë©”ì»¤ë‹ˆì¦˜ (2025 <i>Cell Reports</i>)<br>
â€¢ LLPS (liquid-liquid phase separation) â†’ T6SS assembly<br>
â€¢ "Inside-out" assembly model<br><br>

<b>ë°œí‘œ 4: Stefan Pukatzki (CCNY)</b><br>
â€¢ <i>Vibrio cholerae</i> T6SS<br>
â€¢ <b>Bacterial predation</b> (ì„¸ê· ì´ ì„¸ê· ì„ ê³µê²©!)<br>
â€¢ 100,000-fold E. coli ê°ì†Œ<br>
â€¢ Intraspecies/interguild predation
</td>
<td>75</td>
</tr>
<tr>
<td><b>W1: Bacterial Genome Analysis</b> ğŸ’»</td>
<td>ë°”ì´ì˜¤ì¸í¬</td>
<td>ê²Œë†ˆ ë¶„ì„ ì´ˆë³´ì, ì‹¤ìŠµ ì›í•˜ëŠ” ë¶„</td>
<td>
â€¢ ì„¸ê·  ê²Œë†ˆ ë¶„ì„ ì‹¤ìŠµ ì›Œí¬ìƒµ<br>
â€¢ ì´ˆë³´ì ëŒ€ìƒ (Beginner's Guide)<br>
â€¢ <b>âš ï¸ ìœ ë£Œ, ì‚¬ì „ ë“±ë¡ í•„ìš”</b><br>
â€¢ Hands-on training<br>
â€¢ ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ ê¸°ì´ˆ ë‹¤ì§€ê¸°
</td>
<td>85</td>
</tr>
<tr>
<td>S2: Diet-Microbiome-Host</td>
<td>ë§ˆì´í¬ë¡œë°”ì´ì˜´</td>
<td>ì¥ë‚´ ë¯¸ìƒë¬¼, êµ¬ê°• ë¯¸ìƒë¬¼ ì—°êµ¬ì</td>
<td>
â€¢ Salivary microbiome profiling (ì§„ë‹¨)<br>
â€¢ Amino acid-metabolizing microbes<br>
â€¢ Dietary shiftsì™€ gut symbiont adaptation<br>
â€¢ Diet-microbiome interactions
</td>
<td>50-60</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ ìš°ì„ ìˆœìœ„**:
1. **W1** (ë“±ë¡ ê°€ëŠ¥ ì‹œ) - ê²Œë†ˆ ë¶„ì„ ì‹¤ìŠµ ê¸°íšŒ
2. **S1** (W1 ë¶ˆê°€ ì‹œ ë˜ëŠ” ì„¸ê·  ë³‘ì›ì„± focus) - T6SS, VBNC, MARTX toxin ìµœì‹  ì—°êµ¬
3. S2 (ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì—°êµ¬ì)

---

## Day 2: 10ì›” 27ì¼ (ì›”ìš”ì¼) â­ **ê°€ì¥ í’ì„±í•œ ë‚ **

### â° 09:00-11:00 | ì•„ì¹¨ ì„¸ì…˜

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S4: Respiratory Bacterial Pathogens</b> ğŸ¯</td>
<td>ì„¸ê· í•™, í•­ìƒì œ</td>
<td>AMR, í•­ìƒì œ ê°œë°œ, MRSA/Pseudomonas ì—°êµ¬ì</td>
<td>
<b>ë°œí‘œ 1: Wonsik Lee (SKKU)</b><br>
â€¢ <i>S. aureus</i> niche adaptation<br>
â€¢ 2025 <i>Nature Commun</i>: Tn-Seqìœ¼ë¡œ host niche-specific fitness genes<br>
â€¢ ì„¸í¬ ë‚´ vs. í˜ˆì•¡ vs. ì¥ê¸° = ë‹¤ë¥¸ ìƒì¡´ ìœ ì „ì<br><br>

<b>ë°œí‘œ 2: Sung Jae Shin (Yonsei)</b><br>
â€¢ Mycobacteria (TB + NTM)<br>
â€¢ ì§€ì§ˆ ëŒ€ì‚¬ íƒ€ê²ŸíŒ… ì¹˜ë£Œ<br>
â€¢ NTM = í™˜ê²½ì„± ë³‘ì›ì²´ (ë¬¼ ì‹œìŠ¤í…œ)<br><br>

<b>ë°œí‘œ 3: Jinki Yeom (SNU) â­</b><br>
â€¢ <b>ì‹ ê·œ í•­ìƒì œ í´ë˜ìŠ¤!</b><br>
â€¢ Glycolipid biosynthesis targeting<br>
â€¢ KdsB, WaaA ì–µì œì œ<br>
â€¢ Gram-negative MDR ê·¹ë³µ<br><br>

<b>ë°œí‘œ 4: Changhan Lee (Ajou)</b><br>
â€¢ <i>P. aeruginosa</i> proteostasis<br>
â€¢ FtsH proteases, acid stress response<br><br>

<b>ë°œí‘œ 5: Junho Cho (Yonsei)</b><br>
â€¢ MRSAì˜ AMP (antimicrobial peptide) ì €í•­<br>
â€¢ DltA, MprF (surface charge modification)
</td>
<td><b>95</b></td>
</tr>
<tr>
<td>S3: Protein & Membrane Homeostasis</td>
<td>ì„¸í¬ìƒë¬¼í•™</td>
<td>Proteostasis, ë¦¬ë³´ì†œ, ë§‰ í•­ìƒì„± ì—°êµ¬ì</td>
<td>
â€¢ Peptidoglycan hydrolase proteolysis<br>
â€¢ Ribosome remodeling and repair<br>
â€¢ H3K4 methylation â†’ membrane homeostasis
</td>
<td>40-50</td>
</tr>
<tr>
<td>S5: Fungal Pathogenesis</td>
<td>ì§„ê· í•™</td>
<td>ì§„ê·  ë³‘ì›ì„±, <i>Candida</i>, <i>Cryptococcus</i> ì—°êµ¬ì</td>
<td>
â€¢ <i>Candida auris</i> transcription factor networks<br>
â€¢ Extracellular vesicles in fungal infections<br>
â€¢ Calcineurin downstream targets<br>
â€¢ N-glycan-driven protein QC & EV biogenesis
</td>
<td>70-80 (ì§„ê·  ì „ë¬¸ê°€ì—ê² í•„ìˆ˜)</td>
</tr>
<tr>
<td>S6: Microbial Resources</td>
<td>ë¯¸ìƒë¬¼ ìì›</td>
<td>ê· ì£¼ ë³´ì¡´, ì‚°ì—…í™”, ì •ì±… ê´€ì‹¬ì</td>
<td>
â€¢ KCTC ë¯¸ìƒë¬¼ ìì› ì„¼í„°<br>
â€¢ <i>Bacillus velezensis</i> ì‹¤ìš©í™”<br>
â€¢ Tumor-targeting bacteria<br>
â€¢ ìƒë¬¼ìì› ê´€ë¦¬ ë²•ê·œ
</td>
<td>50-60</td>
</tr>
<tr>
<td><b>W3: R Course (Basic)</b></td>
<td>ë°”ì´ì˜¤ì¸í¬</td>
<td>R ì´ˆë³´ì, ë°ì´í„° ë¶„ì„ ì…ë¬¸</td>
<td>
â€¢ R programming ê¸°ì´ˆ<br>
â€¢ <b>âš ï¸ ìœ ë£Œ, ì‚¬ì „ ë“±ë¡</b><br>
â€¢ ì‹¤ìŠµ ì¤‘ì‹¬
</td>
<td>70-75 (ì´ˆë³´ì)</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ**:
- **ì„¸ê· /AMR ì—°êµ¬ì â†’ S4 í•„ìˆ˜!** (ì‹ ê·œ í•­ìƒì œ íƒ€ê²Ÿ, Jinki Yeom ë°œí‘œ ì£¼ëª©)
- **ì§„ê·  ì—°êµ¬ì â†’ S5**
- **R ì²˜ìŒ ë°°ìš°ëŠ” ë¶„ â†’ W3 (ë“±ë¡ í™•ì¸)**

---

### â° 13:50-15:50 | ì˜¤í›„ ì„¸ì…˜ (ë§¤ìš° ì¤‘ìš”!)

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S8: Diagnosis & Treatment of Bacterial Infections</b> ğŸ”¬</td>
<td>ì§„ë‹¨, AMR</td>
<td>AMR ì§„ë‹¨, Portable diagnostics, í˜„ì¥ ê²€ì‚¬ ê´€ì‹¬ì</td>
<td>
<b>ë°œí‘œ 1: Jeong Wook Lee (POSTECH)</b><br>
â€¢ SENSR (Cell-free RNA detection)<br>
â€¢ 30-50ë¶„, 0.1 attomolar sensitivity<br>
â€¢ SNP discrimination ê°€ëŠ¥<br><br>

<b>ë°œí‘œ 2: Eun-Kyung Lim (KRIBB) â­â­</b><br>
â€¢ <b>CN-TAR: ê³µê¸° ì¤‘ MRSA/VRE ê²€ì¶œ!</b><br>
â€¢ 2025ë…„ ìµœì‹  ì—°êµ¬<br>
â€¢ Cas9 nickase + RCA<br>
â€¢ Portable isothermal device<br>
â€¢ <2ì‹œê°„, 1-2 copies/Î¼L<br><br>

<b>ë°œí‘œ 3: Yoon-Kyoung Cho (UNIST) â­â­</b><br>
â€¢ <b>Fidget spinner SERS!</b><br>
â€¢ 2025 Microsystems & Nanoengineering<br>
â€¢ Hand-powered (ì „ê¸° ë¶ˆí•„ìš”)<br>
â€¢ Species ID in 10-30ë¶„<br>
â€¢ Nanoplasmonic + SERS<br><br>

<b>ë°œí‘œ 4: Moo-seung Lee (KRIBB)</b><br>
â€¢ Shiga toxin detection<br>
â€¢ Graphene FET biosensor<br>
â€¢ Femtogram level, label-free<br><br>

<b>ë°œí‘œ 5: Namil Lee (KAIST)</b><br>
â€¢ <i>Streptomyces</i> synthetic biology<br>
â€¢ BGC activation, ì‹ ê·œ í•­ìƒì œ ë°œêµ´
</td>
<td><b>98</b></td>
</tr>
<tr>
<td>S10: Green Microbiome</td>
<td>í™˜ê²½, ì‹ë¬¼</td>
<td>Plant microbiome, ë†ì—… ë¯¸ìƒë¬¼ ì—°êµ¬ì</td>
<td>
<b>ë°œí‘œ 1: Rodrigo Taketani (Rothamsted, UK)</b><br>
â€¢ UK Crop Microbiome Cryobank<br>
â€¢ 6ê°€ì§€ ì£¼ìš” ì‘ë¬¼ (Barley, Wheat, OSR ë“±)<br>
â€¢ 9ê°œ UK í† ì–‘ ìœ í˜•<br>
â€¢ ì„¸ê³„ ìµœì´ˆ ê³µê°œ ìì›<br><br>

<b>ë°œí‘œ 2: Jae-Ho Shin (Kyungpook)</b><br>
â€¢ Plant immunity microbiome engineering<br>
â€¢ Pathogen-suppressive microbiome<br>
â€¢ Practical rules for microbiome design<br><br>

<b>ë°œí‘œ 3-5</b>:<br>
â€¢ Rice blast + rhizosphere microbes<br>
â€¢ Hanwoo (í•œìš°) intestinal microbiome<br>
â€¢ Green microbiome data standardization
</td>
<td>75-80</td>
</tr>
<tr>
<td>S7: Viral Research & Pandemic</td>
<td>ë°”ì´ëŸ¬ìŠ¤í•™</td>
<td>ë°”ì´ëŸ¬ìŠ¤, ë°±ì‹ , íŒ¬ë°ë¯¹ ëŒ€ì‘ ì—°êµ¬ì</td>
<td>
â€¢ Host-directed therapy (í˜¸í¡ê¸° ë°”ì´ëŸ¬ìŠ¤)<br>
â€¢ HBV receptor NTCP êµ¬ì¡°<br>
â€¢ AIë¡œ ë°±ì‹  ê°œë°œ (structure-based)<br>
â€¢ Emerging viruses ëŒ€ì‘ ì „ëµ
</td>
<td>75-80 (ë°”ì´ëŸ¬ìŠ¤ ì „ë¬¸ê°€)</td>
</tr>
<tr>
<td>S11: Industrial Innovation</td>
<td>ì‚°ì—…, ì‘ìš©</td>
<td>Probiotics, ì‚°ì—…í™”, ê¸°ëŠ¥ì„± ì‹í’ˆ ê´€ì‹¬ì</td>
<td>
â€¢ Prebiotic carbohydrates + probiotics<br>
â€¢ Microbiome-derived probiotics ìƒìš©í™”<br>
â€¢ Next-generation probiotics<br>
â€¢ QIAcuity dPCR system
</td>
<td>60-70</td>
</tr>
<tr>
<td>S9: WiKim-BKRI Biobank</td>
<td>ìì›, ê¹€ì¹˜</td>
<td>ë°œíš¨ ë¯¸ìƒë¬¼, ê¹€ì¹˜, í”„ë¡œë°”ì´ì˜¤í‹±ìŠ¤ ì—°êµ¬ì</td>
<td>
â€¢ Bank of Kimchi Resources and Information<br>
â€¢ Anti-obesity probiotic (kimchi-derived)<br>
â€¢ Fermented microorganism database<br>
â€¢ Panel discussion
</td>
<td>55-65</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ**:
- **ì§„ë‹¨/AMR â†’ S8 ìµœìš°ì„ !** (CN-TAR, Fidget spinner í˜ì‹  ê¸°ìˆ )
- **Plant microbiome â†’ S10**
- **ë°”ì´ëŸ¬ìŠ¤ â†’ S7**

---

### â° 16:00-18:00 | ì €ë… ì„¸ì…˜

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S12: Environment - Hidden Jewels</b> ğŸŒ</td>
<td>í™˜ê²½, ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤</td>
<td>í™˜ê²½ ë¯¸ìƒë¬¼, ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤, Single-cell genomics ê´€ì‹¬ì</td>
<td>
<b>ë°œí‘œ 1: Yusuke Okazaki (Kyoto) â­</b><br>
â€¢ Lake bacteria single-cell genomics<br>
â€¢ Genomic individuality & ecological strategies<br>
â€¢ Oligotrophs vs. Copiotrophs<br>
â€¢ Long-read metagenomics (complete MAGs)<br>
â€¢ Virus-host pairing<br><br>

<b>ë°œí‘œ 2: Sung-Keun Rhee (Chungbuk)</b><br>
â€¢ Methanotrophs reduce Nâ‚‚O!<br>
â€¢ 2024 <i>Nature Commun</i><br>
â€¢ Dual benefit: CHâ‚„ oxidation + Nâ‚‚O reduction<br>
â€¢ Wetland mitigation<br><br>

<b>ë°œí‘œ 3: Haiyan Chu (Chinese Academy)</b><br>
â€¢ Soil microbial biogeography (China + Global)<br>
â€¢ pH = strongest predictor<br>
â€¢ Climate change impacts<br>
â€¢ Highly cited researcher<br><br>

<b>ë°œí‘œ 4-5 (Short)</b>:<br>
â€¢ Antarctic subglacial microbiome (KOPRI)<br>
â€¢ Freshwater gene catalogue (Inha Univ)
</td>
<td><b>88</b></td>
</tr>
<tr>
<td>S14: Proteomics</td>
<td>ì˜¤ë¯¹ìŠ¤</td>
<td>Proteomics, Multi-omics ì—°êµ¬ì</td>
<td>
â€¢ Olink proteomics (gut-lung axis)<br>
â€¢ Illumina protein prep<br>
â€¢ AI-powered bioinformatics SaaS
</td>
<td>70-75</td>
</tr>
<tr>
<td>S16: Vaccine Technologies</td>
<td>ë°±ì‹ í•™</td>
<td>ë°±ì‹  ê°œë°œ, ë©´ì—­í•™ ì—°êµ¬ì</td>
<td>
â€¢ Next-generation vaccine platforms<br>
â€¢ Structure-based design<br>
â€¢ Universal protection strategies<br>
â€¢ Influenza, JEV, RSV vaccines
</td>
<td>75-80 (ë°±ì‹  ì „ë¬¸ê°€)</td>
</tr>
<tr>
<td>S13: Macromolecular Systems</td>
<td>êµ¬ì¡°ìƒë¬¼í•™</td>
<td>ë‹¨ë°±ì§ˆ êµ¬ì¡°, Cell division ì—°êµ¬ì</td>
<td>
â€¢ Bacterial cell division proteins<br>
â€¢ AAA+ proteases activity control<br>
â€¢ AlaRS fidelity evolution<br>
â€¢ CRISPR-Cas13a delivery (LNP)
</td>
<td>60-70</td>
</tr>
<tr>
<td>S15: Gut-Skin-Immune Axis</td>
<td>ë§ˆì´í¬ë¡œë°”ì´ì˜´</td>
<td>Probiotics, Skin health, Gut-skin axis ê´€ì‹¬ì</td>
<td>
â€¢ <i>Lactiplantibacillus plantarum</i> anti-atopic<br>
â€¢ Bacterial vaginosis probiotics<br>
â€¢ Exopolysaccharide as postbiotics<br>
â€¢ Metabolomics-guided ingredient discovery
</td>
<td>55-65</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ**:
- **í™˜ê²½ ë¯¸ìƒë¬¼/ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ â†’ S12** (Single-cell genomics!)
- **Proteomics â†’ S14**
- **ë°±ì‹  â†’ S16**

---

## Day 3: 10ì›” 28ì¼ (í™”ìš”ì¼)

### â° 09:00-11:00 | ì•„ì¹¨ ì„¸ì…˜

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S17: Zoonosis - One Health</b> ğŸ¾</td>
<td>One Health</td>
<td>ì¸ìˆ˜ê³µí†µê°ì—¼ë³‘, ë°±ì‹ , AMR stewardship ì—°êµ¬ì</td>
<td>
<b>ë°œí‘œ 1: Jun-Gu Kang (Jeonbuk)</b><br>
â€¢ <i>Bandavirus dabieense</i> vaccine<br>
â€¢ Dog & mouse models<br>
â€¢ Severe fever with thrombocytopenia syndrome<br><br>

<b>ë°œí‘œ 2: Jung Hyang Sur (Komipharm)</b><br>
â€¢ ASFV (African swine fever) live attenuated vaccine<br>
â€¢ Pregnant sows & growing pigs safety<br>
â€¢ Long-term antibody maintenance<br><br>

<b>ë°œí‘œ 3: Kwang-Won Seo (Chungbuk)</b><br>
â€¢ Antimicrobial stewardship in swine production<br>
â€¢ Zoonosis reduction<br><br>

<b>ë°œí‘œ 4-5</b>:<br>
â€¢ SARS-CoV-2 reverse genetics â†’ Flavivirus platforms<br>
â€¢ Exosome-mediated immune pathology
</td>
<td>80-85</td>
</tr>
<tr>
<td>S18: Biosystems Design & Synthesis</td>
<td>í•©ì„±ìƒë¬¼í•™</td>
<td>Synthetic biology, Metabolic engineering ì—°êµ¬ì</td>
<td>
â€¢ Plastic upcycling via evolution<br>
â€¢ Translational coupling bioparts<br>
â€¢ ML-derived modules<br>
â€¢ Acetogenic bacteria for C1 gas bioconversion
</td>
<td>70-75</td>
</tr>
<tr>
<td>S19: Biosafety & LMO</td>
<td>ìƒë¬¼ì•ˆì „</td>
<td>LMO ê´€ë¦¬, ê·œì œ ê´€ì‹¬ì</td>
<td>
â€¢ LMO Act & regulations<br>
â€¢ R&D LMO facilities safety management<br>
â€¢ Compliance improvement<br>
â€¢ <i>(ê·œì œ ì¤‘ì‹¬, ì—°êµ¬ ë‚´ìš© ì ìŒ)</i>
</td>
<td>35-45</td>
</tr>
<tr>
<td>GS2: Graduate Students' Forum 2</td>
<td>ëŒ€í•™ì›ìƒ</td>
<td>ëŒ€í•™ì›ìƒ (ì„/ë°•ì‚¬ê³¼ì •)</td>
<td>
â€¢ ëŒ€í•™ì›ìƒ ë°œí‘œ ì„¸ì…˜<br>
â€¢ Networking ê¸°íšŒ
</td>
<td>50-60 (ëŒ€í•™ì›ìƒ)</td>
</tr>
<tr>
<td><b>W4: R Course (Advanced)</b></td>
<td>ë°”ì´ì˜¤ì¸í¬</td>
<td>R ì¤‘ê¸‰ì, ê³ ê¸‰ ë¶„ì„ ì›í•˜ëŠ” ë¶„</td>
<td>
â€¢ R programming ê³ ê¸‰<br>
â€¢ <b>âš ï¸ ìœ ë£Œ, ì‚¬ì „ ë“±ë¡</b><br>
â€¢ ì‹¤ìŠµ
</td>
<td>80-85 (ì¤‘ê¸‰ì)</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ**:
- **One Health/Zoonosis â†’ S17**
- **Synthetic biology â†’ S18**
- **R ê²½í—˜ì â†’ W4**

---

### â° 14:00-16:00 | ë§ˆì§€ë§‰ ì„¸ì…˜

<table>
<tr><th>ì„¸ì…˜</th><th>ë¶„ì•¼</th><th>ì¶”ì²œ ëŒ€ìƒ</th><th>í•µì‹¬ ë‚´ìš©</th><th>ì ìˆ˜</th></tr>
<tr>
<td><b>S20: Epidemic Disasters</b> ğŸš¨</td>
<td>ê³µì¤‘ë³´ê±´</td>
<td>íŒ¬ë°ë¯¹ ëŒ€ì‘, ë°±ì‹ , ê°ì‹œ ì²´ê³„ ê´€ì‹¬ì</td>
<td>
<b>ë°œí‘œ 1: Hyun Park (Wonkwang)</b><br>
â€¢ Avian influenza H5 (clade 2.3.4.4b)<br>
â€¢ Neutralizing antibodies<br>
â€¢ Vaccine design & therapeutics<br><br>

<b>ë°œí‘œ 2: Seung Pil Yun (Gyeongsang)</b><br>
â€¢ SARS-CoV-2 + Parkinson's disease progression<br><br>

<b>ë°œí‘œ 3: Hyunjoo Cha-Molstad (KRIBB) â­</b><br>
â€¢ <b>Ionizable LNP + mRNA vaccines</b><br>
â€¢ 2025ë…„ ìµœì‹  ì—°êµ¬<br>
â€¢ Transition temperature-guided design<br>
â€¢ Next-generation vaccine engineering<br><br>

<b>ë°œí‘œ 4-5</b>:<br>
â€¢ African swine fever variants (Asia)<br>
â€¢ ASFV cell-adapted live attenuated vaccine
</td>
<td>78-82</td>
</tr>
<tr>
<td>S21: KMB-MSK Joint Symposium</td>
<td>ë¯¸ìƒë¬¼ ìƒëª…ê³µí•™</td>
<td>ì‚°ì—… ë¯¸ìƒë¬¼, Metabolic engineering ê´€ì‹¬ì</td>
<td>
â€¢ C50 carotenoid bacterioruberin<br>
â€¢ Microalgal biotechnology<br>
â€¢ <i>Lactobacillus</i> metabolic responses<br>
â€¢ Cyanobacterial bloom control
</td>
<td>68-72</td>
</tr>
<tr>
<td><b>W5: Statistics for Microbiologist</b></td>
<td>í†µê³„</td>
<td>í†µê³„ ë¶„ì„ ë°°ìš°ê³  ì‹¶ì€ ëª¨ë“  ì—°êµ¬ì</td>
<td>
â€¢ ë¯¸ìƒë¬¼í•™ìë¥¼ ìœ„í•œ í†µê³„<br>
â€¢ <b>âš ï¸ ìœ ë£Œ, ì‚¬ì „ ë“±ë¡</b><br>
â€¢ ì‹¤ìŠµ ì¤‘ì‹¬<br>
â€¢ ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ ë°ì´í„° í†µê³„
</td>
<td><b>82-85</b></td>
</tr>
<tr>
<td>GS3, GS4: Graduate Forums</td>
<td>ëŒ€í•™ì›ìƒ</td>
<td>ëŒ€í•™ì›ìƒ</td>
<td>
â€¢ ëŒ€í•™ì›ìƒ ë°œí‘œ<br>
â€¢ 2ê°œ ë³‘ë ¬ ì„¸ì…˜
</td>
<td>50-60</td>
</tr>
</table>

**ğŸ’¡ ì¶”ì²œ**:
- **W5 (ë“±ë¡ ê°€ëŠ¥ ì‹œ)** - í†µê³„ ë¶„ì„ ì—­ëŸ‰ ê°•í™”
- **S20 (ëŒ€ì•ˆ)** - íŒ¬ë°ë¯¹ ëŒ€ì‘, LNP vaccine
- S21 (ì‚°ì—… ë¯¸ìƒë¬¼)

---

# ğŸ¯ ë¶„ì•¼ë³„ ë§ì¶¤ ì¶”ì²œ

## ì„¸ê· í•™ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S4** (10/27 09:00) - í•­ìƒì œ ì‹ ê·œ íƒ€ê²Ÿ â­â­â­
2. **S8** (10/27 13:50) - ì§„ë‹¨ ê¸°ìˆ  â­â­â­
3. **S1** (10/26 13:30) - ë³‘ì›ì„± ë©”ì»¤ë‹ˆì¦˜ â­â­

### ì¶”ì²œ ì„¸ì…˜
- S17 (One Health AMR)
- S12 (í™˜ê²½ ë¯¸ìƒë¬¼)

### ì£¼ëª©í•  ì—°ì‚¬
- Jinki Yeom (SNU) - Glycolipid biosynthesis targeting
- Eun-Kyung Lim (KRIBB) - Airborne AMR detection
- Tao Dong (SUSTech) - T6SS phase separation
- Wonsik Lee (SKKU) - Niche adaptation

---

## ë°”ì´ëŸ¬ìŠ¤í•™ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S7** (10/27 13:50) - Viral research & pandemic â­â­â­
2. **S16** (10/27 16:00) - Vaccine technologies â­â­â­
3. **S20** (10/28 14:00) - Epidemic disasters â­â­

### ì¶”ì²œ ì„¸ì…˜
- S17 (Zoonosis - SFTSV, ASFV)

### ì£¼ëª©í•  ë°œí‘œ
- AIë¡œ ë°±ì‹  ê°œë°œ (S7)
- LNP-mRNA vaccines (S20 - Hyunjoo Cha-Molstad)
- Structure-based vaccine design (S16)
- ASFV/H5 vaccines (S17, S20)

---

## ì§„ê· í•™ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S5** (10/27 09:00) - Fungal pathogenesis â­â­â­

### ì£¼ëª©í•  ë°œí‘œ
- *Candida auris* transcription networks
- Extracellular vesicles in fungal infections
- N-glycan-driven protein QC

---

## í™˜ê²½/ë§ˆì´í¬ë¡œë°”ì´ì˜´ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S12** (10/27 16:00) - Environment â­â­â­
2. **S10** (10/27 13:50) - Green microbiome â­â­â­
3. **S2** (10/26 13:30) - Diet-microbiome â­â­

### ì¶”ì²œ ì„¸ì…˜
- S9 (Kimchi microbiome)
- S11 (Industrial probiotics)
- S15 (Gut-skin axis)

### ì£¼ëª©í•  ì—°ì‚¬
- Yusuke Okazaki (Kyoto) - Single-cell genomics
- Haiyan Chu (Chinese Academy) - Soil biogeography
- Rodrigo Taketani (Rothamsted) - UK Crop Microbiome Cryobank
- Jae-Ho Shin (Kyungpook) - Microbiome engineering

---

## ë°”ì´ì˜¤ì¸í¬/ì˜¤ë¯¹ìŠ¤ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **W1** (10/26 13:30) - Genome analysis (Basic) â­â­
2. **W5** (10/28 14:00) - Statistics â­â­â­
3. **S14** (10/27 16:00) - Proteomics â­â­

### ì¶”ì²œ ì„¸ì…˜
- W4 (R advanced) - 10/28 09:00
- S12 (Metagenomics methods)

### ì£¼ëª©í•  ë‚´ìš©
- Single-cell genomics (S12 - Okazaki)
- Long-read metagenomics
- AI-powered bioinformatics
- Multi-omics integration

---

## í•©ì„±ìƒë¬¼í•™/ëŒ€ì‚¬ê³µí•™ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S18** (10/28 09:00) - Biosystems design â­â­â­
2. **S21** (10/28 14:00) - Microbial biotechnology â­â­

### ì¶”ì²œ ì„¸ì…˜
- S8 ë°œí‘œ 5 (Namil Lee - *Streptomyces*)

### ì£¼ëª©í•  ë‚´ìš©
- ML-derived modules
- Plastic upcycling via evolution
- Acetogenic bacteria for C1 gas
- Carotenoid production

---

## ë°±ì‹ /ë©´ì—­í•™ ì—°êµ¬ì

### í•„ìˆ˜ ì„¸ì…˜
1. **S16** (10/27 16:00) - Vaccine technologies â­â­â­
2. **S20** (10/28 14:00) - Epidemic disasters â­â­â­
3. **S7** (10/27 13:50) - Viral research â­â­

### ì¶”ì²œ ì„¸ì…˜
- S17 (Zoonosis vaccines)

### ì£¼ëª©í•  ì—°ì‚¬
- Hyunjoo Cha-Molstad (KRIBB) - LNP-mRNA vaccines
- Manki Song (IVI) - Next-generation vaccines
- Jun-Gu Kang (Jeonbuk) - SFTSV vaccine

---

# ğŸ“Š MECE ì‹œê°„ëŒ€ ì˜ì‚¬ê²°ì • íŠ¸ë¦¬

## Day 1 (10/26 ì¼) 13:30-15:30

```
ë‹¹ì‹ ì˜ ì—°êµ¬ ë¶„ì•¼ëŠ”?
â”‚
â”œâ”€ ì„¸ê·  ë³‘ì›ì„± â†’ S1 (T6SS, VBNC, MARTX)
â”‚  â””â”€ ë°”ì´ì˜¤ì¸í¬ ì´ˆë³´ì? â†’ W1 (Genome workshop)
â”‚
â”œâ”€ ë§ˆì´í¬ë¡œë°”ì´ì˜´ â†’ S2 (Diet-microbiome)
â”‚
â””â”€ ë°”ì´ì˜¤ì¸í¬ ì´ˆë³´ì â†’ W1 â­
```

## Day 2 (10/27 ì›”) 09:00-11:00

```
ë‹¹ì‹ ì˜ ì—°êµ¬ ë¶„ì•¼ëŠ”?
â”‚
â”œâ”€ ì„¸ê· /AMR â†’ S4 â­â­â­ (í•„ìˆ˜!)
â”‚
â”œâ”€ ì§„ê·  â†’ S5
â”‚
â”œâ”€ Proteostasis/ì„¸í¬ìƒë¬¼ â†’ S3
â”‚
â”œâ”€ ë¯¸ìƒë¬¼ ìì›/ì‚°ì—…í™” â†’ S6
â”‚
â””â”€ R ì´ˆë³´ì â†’ W3
```

## Day 2 (10/27 ì›”) 13:50-15:50

```
ë‹¹ì‹ ì˜ ìš°ì„ ìˆœìœ„ëŠ”?
â”‚
â”œâ”€ AMR ì§„ë‹¨/ê¸°ìˆ  â†’ S8 â­â­â­ (ìµœìš°ì„ !)
â”‚  â”œâ”€ Portable diagnostics í¥ë¯¸
â”‚  â””â”€ CN-TAR, Fidget spinner
â”‚
â”œâ”€ ì‹ë¬¼ ë¯¸ìƒë¬¼ â†’ S10 (Green microbiome)
â”‚
â”œâ”€ ë°”ì´ëŸ¬ìŠ¤/ë°±ì‹  â†’ S7
â”‚
â”œâ”€ ì‚°ì—…/í”„ë¡œë°”ì´ì˜¤í‹±ìŠ¤ â†’ S11
â”‚
â””â”€ ê¹€ì¹˜ ë¯¸ìƒë¬¼ â†’ S9
```

## Day 2 (10/27 ì›”) 16:00-18:00

```
ë‹¹ì‹ ì˜ ê´€ì‹¬ì‚¬ëŠ”?
â”‚
â”œâ”€ í™˜ê²½ ë¯¸ìƒë¬¼/ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ â†’ S12 â­â­â­
â”‚  â”œâ”€ Single-cell genomics ë°°ìš°ê³  ì‹¶ë‹¤
â”‚  â””â”€ Biogeography ê´€ì‹¬
â”‚
â”œâ”€ Proteomics â†’ S14
â”‚
â”œâ”€ ë°±ì‹  â†’ S16
â”‚
â”œâ”€ êµ¬ì¡°ìƒë¬¼í•™ â†’ S13
â”‚
â””â”€ Gut-skin axis â†’ S15
```

## Day 3 (10/28 í™”) 09:00-11:00

```
ë‹¹ì‹ ì˜ ì—°êµ¬ ë¶„ì•¼ëŠ”?
â”‚
â”œâ”€ One Health/Zoonosis â†’ S17 â­â­
â”‚
â”œâ”€ Synthetic biology â†’ S18
â”‚
â”œâ”€ LMO ê·œì œ â†’ S19 (ë‚®ì€ ìš°ì„ ìˆœìœ„)
â”‚
â”œâ”€ ëŒ€í•™ì›ìƒ â†’ GS2
â”‚
â””â”€ R ì¤‘ê¸‰ì â†’ W4
```

## Day 3 (10/28 í™”) 14:00-16:00

```
ë‹¹ì‹ ì˜ ìš°ì„ ìˆœìœ„ëŠ”?
â”‚
â”œâ”€ í†µê³„ ë°°ìš°ê³  ì‹¶ë‹¤ â†’ W5 â­â­â­ (ê°•ë ¥ ì¶”ì²œ!)
â”‚  â””â”€ ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ ë°ì´í„° ë¶„ì„
â”‚
â”œâ”€ íŒ¬ë°ë¯¹ ëŒ€ì‘/ë°±ì‹  â†’ S20
â”‚  â””â”€ LNP-mRNA vaccines í¥ë¯¸
â”‚
â”œâ”€ ì‚°ì—… ë¯¸ìƒë¬¼ â†’ S21
â”‚
â””â”€ ëŒ€í•™ì›ìƒ â†’ GS3, GS4
```

---

# âš¡ ë¹ ë¥¸ ì²´í¬ë¦¬ìŠ¤íŠ¸

## ì‚¬ì „ ì¤€ë¹„ (í•™íšŒ ì „)

### ë“±ë¡ í™•ì¸
- [ ] **ì›Œí¬ìƒµ ì‚¬ì „ ë“±ë¡** (W1, W3, W4, W5) - ìœ ë£Œ, ì„ ì°©ìˆœ
- [ ] í•™íšŒ ë“±ë¡ ì™„ë£Œ
- [ ] ìˆ™ì†Œ ì˜ˆì•½ (ëŒ€ì „ì»¨ë²¤ì…˜ì„¼í„° ì¸ê·¼)

### ìë£Œ ì¤€ë¹„
- [ ] ëª…í•¨ ì¤€ë¹„ (í•œê¸€/ì˜ë¬¸ ê° 20ì¥)
- [ ] ê´€ì‹¬ ì„¸ì…˜ í¬ìŠ¤í„° ì´ˆë¡ ë¯¸ë¦¬ í™•ì¸
- [ ] ì—°ì‚¬ ìµœê·¼ ë…¼ë¬¸ 1-2ê°œì”© ì½ê¸° (ê´€ì‹¬ ì„¸ì…˜)
- [ ] ì§ˆë¬¸ ë¦¬ìŠ¤íŠ¸ ì¤€ë¹„

### ì¥ë¹„
- [ ] ë…¸íŠ¸ë¶/íƒœë¸”ë¦¿ + ì¶©ì „ê¸°
- [ ] ë³¼íœ, ë…¸íŠ¸
- [ ] ì¹´ë©”ë¼/ìŠ¤ë§ˆíŠ¸í° (ìŠ¬ë¼ì´ë“œ ì´¬ì˜ìš©, í—ˆìš© ì‹œ)

## í•™íšŒ ë‹¹ì¼

### Day 1 (10/26 ì¼)
- [ ] 12:30 ë„ì°© (Registration)
- [ ] 13:30 ì²« ì„¸ì…˜ ì°¸ì„
- [ ] 16:30 Poster Session 1 - ë„¤íŠ¸ì›Œí‚¹
- [ ] ì €ë…: ë‚´ì¼ ì¼ì • í™•ì¸

### Day 2 (10/27 ì›”) â­
- [ ] 08:30 ë„ì°©
- [ ] 09:00 S4 ì°¸ì„ (í•„ìˆ˜!)
- [ ] 11:10 PL2 ì°¸ì„
- [ ] 13:00 PL3 ì°¸ì„
- [ ] 13:50 S8 ì°¸ì„ (ìµœìš°ì„ !)
- [ ] 16:00 S12 ì°¸ì„
- [ ] 18:00 Poster Session 2 - ë„¤íŠ¸ì›Œí‚¹
- [ ] ì¤‘ìš” ì—°ì‚¬ì™€ ëª…í•¨ êµí™˜, ë©”ëª¨

### Day 3 (10/28 í™”)
- [ ] 08:30 ë„ì°©
- [ ] 09:00 ì„¸ì…˜ ì°¸ì„
- [ ] 13:00 MSK Award Lecture ì°¸ì„
- [ ] 14:00 W5 ë˜ëŠ” S20 ì°¸ì„
- [ ] 16:00 Closing Ceremony
- [ ] Follow-up ê³„íš ì •ë¦¬

## í•™íšŒ í›„

### ì¦‰ì‹œ (3ì¼ ë‚´)
- [ ] ëª…í•¨ ì •ë¦¬ & ë’·ë©´ ë©”ëª¨ í™•ì¸
- [ ] ì¤‘ìš” ì—°ì‚¬ 5ëª…ì—ê²Œ follow-up email
- [ ] ë© ë¯¸íŒ…ì—ì„œ í•™íšŒ ë‚´ìš© ê³µìœ 
- [ ] ë°°ìš´ ê¸°ë²•/ì•„ì´ë””ì–´ë¥¼ ì—°êµ¬ì— ì ìš© ê³„íš ìˆ˜ë¦½

### ì¤‘ê¸° (2ì£¼ ë‚´)
- [ ] ê´€ì‹¬ ì—°ì‚¬ ë…¼ë¬¸ ì½ê¸°
- [ ] Collaborative study ì œì•ˆì„œ ì‘ì„± (í•´ë‹¹ ì‹œ)
- [ ] í•™íšŒì—ì„œ ë°°ìš´ ê¸°ë²• ì‹¤í—˜ì‹¤ ë„ì… ê²€í† 

---

# ğŸ¤ ë„¤íŠ¸ì›Œí‚¹ ì „ëµ

## ëˆ„êµ¬ì™€ ë„¤íŠ¸ì›Œí‚¹?

### ì—°êµ¬ ë¶„ì•¼ë³„ ìš°ì„  íƒ€ê²Ÿ

**ì„¸ê· /AMR ì—°êµ¬ì**:
1. **Eun-Kyung Lim** (KRIBB) - CN-TAR, Airborne AMR
2. **Jinki Yeom** (SNU) - ì‹ ê·œ í•­ìƒì œ
3. **Yoon-Kyoung Cho** (UNIST) - Fidget spinner SERS
4. **Wonsik Lee** (SKKU) - Tn-Seq, Niche adaptation
5. **Tao Dong** (SUSTech) - T6SS

**í™˜ê²½/ë©”íƒ€ì§€ë…¸ë¯¹ìŠ¤ ì—°êµ¬ì**:
1. **Yusuke Okazaki** (Kyoto) - Single-cell genomics
2. **Haiyan Chu** (Chinese Academy) - Biogeography
3. **Hongjae Park** (Inha) - êµ­ë‚´, Freshwater genomics
4. **Rodrigo Taketani** (Rothamsted) - Crop microbiome

**ë°”ì´ëŸ¬ìŠ¤/ë°±ì‹  ì—°êµ¬ì**:
1. **Hyunjoo Cha-Molstad** (KRIBB) - LNP-mRNA vaccines
2. **Manki Song** (IVI) - Vaccine development
3. **Jun-Gu Kang** (Jeonbuk) - SFTSV vaccine

## ì–´ë–»ê²Œ ë„¤íŠ¸ì›Œí‚¹?

### ë°œí‘œ ì¤‘
1. **ì ê·¹ì  ì§ˆë¬¸**: ë°œí‘œ ì§í›„ Q&A ì‹œê°„ í™œìš©
2. **ë©”ëª¨**: ì—°ì‚¬ ì—°ë½ì²˜, í•µì‹¬ ë‚´ìš©, follow-up í¬ì¸íŠ¸
3. **ìŠ¬ë¼ì´ë“œ ì´¬ì˜** (í—ˆìš© ì‹œ)

### ë°œí‘œ ì§í›„
1. **ì§ì ‘ ì ‘ê·¼**: "ë°œí‘œ ì˜ ë“¤ì—ˆìŠµë‹ˆë‹¤. ì €ëŠ” ___ì„ ì—°êµ¬í•˜ëŠ”ë°, ___ì´ ê¶ê¸ˆí•©ë‹ˆë‹¤."
2. **ëª…í•¨ êµí™˜**: ì¦‰ì‹œ ë’·ë©´ì— ë©”ëª¨ (ë‚ ì§œ, ì„¸ì…˜, ëŒ€í™” ë‚´ìš©)
3. **ê°„ë‹¨í•œ ì•„ì´ë””ì–´ êµí™˜**: 3-5ë¶„ ëŒ€í™”

### Poster Session
1. **ê³„íšì  íƒìƒ‰**: ì‚¬ì „ì— ê´€ì‹¬ í¬ìŠ¤í„° ë¦¬ìŠ¤íŠ¸ì—…
2. **Standing reception**: Informal ëŒ€í™” ê¸°íšŒ
3. **ì—°ë½ì²˜ ìˆ˜ì§‘**

### Follow-up Email (3ì¼ ë‚´)

```
Subject: MSK2025ì—ì„œ ëµŒ [Your Name]ì…ë‹ˆë‹¤ - [ì£¼ì œ] ê´€ë ¨

Dear Dr. [Name],

MSK2025 [ì„¸ì…˜ëª…]ì—ì„œ ì„ ìƒë‹˜ì˜ ë°œí‘œ "[ë°œí‘œ ì œëª©]"ë¥¼
í¥ë¯¸ë¡­ê²Œ ë“¤ì—ˆìŠµë‹ˆë‹¤. íŠ¹íˆ [êµ¬ì²´ì  ë‚´ìš©]ì´ ì¸ìƒ ê¹Šì—ˆìŠµë‹ˆë‹¤.

ì €ëŠ” í˜„ì¬ [ì—°êµ¬ ì£¼ì œ]ë¥¼ ì—°êµ¬í•˜ê³  ìˆìœ¼ë©°, ì„ ìƒë‹˜ì˜ [ê¸°ë²•/ë°œê²¬]ì„
[ì ìš© ë°©ë²•]ì— í™œìš©í•˜ê³ ì í•©ë‹ˆë‹¤.

[Specific question 1-2ê°œ]

í˜¹ì‹œ [Collaboration/Technical discussion] ê°€ëŠ¥í•˜ì‹¤ê¹Œìš”?

ê°ì‚¬í•©ë‹ˆë‹¤.

[Your Name]
[Affiliation]
[Email]
```

---

# ğŸ“– ë°œí‘œ ìš”ì•½ Quick Reference

## í˜ì‹ ì  ê¸°ìˆ  Top 5

1. **CN-TAR** (Eun-Kyung Lim, KRIBB) - ê³µê¸° ì¤‘ AMR ê²€ì¶œ
2. **Fidget Spinner SERS** (Yoon-Kyoung Cho, UNIST) - Hand-powered species ID
3. **Glycolipid Biosynthesis Inhibitors** (Jinki Yeom, SNU) - ì‹ ê·œ í•­ìƒì œ
4. **Single-cell Genomics** (Yusuke Okazaki, Kyoto) - Strain-level resolution
5. **LNP-mRNA Vaccines** (Hyunjoo Cha-Molstad, KRIBB) - Next-gen vaccines

## Must-Read ë…¼ë¬¸ (ì‚¬ì „ ì¤€ë¹„)

1. **Wonsik Lee** (2025) - Nature Communications, S. aureus niche adaptation
2. **Eun-Kyung Lim** (2025) - CN-TAR airborne AMR detection
3. **Yoon-Kyoung Cho** (2025) - Microsystems & Nanoengineering, Fidget spinner
4. **Tao Dong** (2025) - Cell Reports, T6SS phase separation
5. **Sung-Keun Rhee** (2024) - Nature Communications, Methanotroph N2O respiration

---

# ğŸ“ ëŒ€í•™ì›ìƒ íŠ¹ë³„ ê°€ì´ë“œ

## Graduate Students' Forum

- **GS1** (10/26 13:30) - Forum 1
- **GS2** (10/28 09:00) - Forum 2
- **GS3, GS4** (10/28 14:00) - Forums 3 & 4

### ëŒ€í•™ì›ìƒ ì¶”ì²œ ì „ëµ

**ì—°êµ¬ ì´ˆê¸° (ì„ì‚¬ 1-2ë…„ì°¨)**:
- Workshops ìš°ì„  (W1, W5) - ê¸°ì´ˆ ë‹¤ì§€ê¸°
- Broad sessions (S1, S12) - ë‹¤ì–‘í•œ ë¶„ì•¼ íƒìƒ‰
- GS Forums - ë™ë£Œ ë„¤íŠ¸ì›Œí‚¹

**ì—°êµ¬ ì¤‘ê¸° (ë°•ì‚¬ 2-3ë…„ì°¨)**:
- ë¶„ì•¼ë³„ ì „ë¬¸ ì„¸ì…˜ ì§‘ì¤‘
- ì—°ì‚¬ì™€ ì ê·¹ì  ë„¤íŠ¸ì›Œí‚¹
- Poster ë°œí‘œ ì¤€ë¹„ (í•´ë‹¹ ì‹œ)

**ì—°êµ¬ í›„ê¸° (ë°•ì‚¬ 4ë…„ì°¨+, ë°•ì‚¬í›„ì—°êµ¬ì›)**:
- Cutting-edge ì„¸ì…˜ (S4, S8, S12)
- PIê¸‰ ì—°ì‚¬ì™€ ì‹¬ë„ ìˆëŠ” í† ë¡ 
- Collaboration ê¸°íšŒ íƒìƒ‰

---

# ğŸ’¡ ë§ˆì§€ë§‰ Tips

## ì„¸ì…˜ ì„ íƒ ìš°ì„ ìˆœìœ„

1. **í•„ìˆ˜ ì„¸ì…˜** (ë¶„ì•¼ ìµœì‹  ì—°êµ¬) â†’ ë†“ì¹˜ë©´ ì•ˆ ë¨
2. **ê¸°ë²• í•™ìŠµ** (Workshops, Methodology) â†’ ì¦‰ì‹œ í™œìš© ê°€ëŠ¥
3. **ë„¤íŠ¸ì›Œí‚¹** (Collaborative ê¸°íšŒ) â†’ ì¥ê¸°ì  ê°€ì¹˜
4. **Broad exposure** (ìƒˆë¡œìš´ ë¶„ì•¼ íƒìƒ‰) â†’ ì°½ì˜ì  ì•„ì´ë””ì–´

## íš¨ìœ¨ì  í•™íšŒ ì°¸ì„ë²•

- **80-20 Rule**: 20%ì˜ ì„¸ì…˜ì´ 80%ì˜ ê°€ì¹˜ ì œê³µ
  - í•µì‹¬ 3-4 ì„¸ì…˜ì— ì§‘ì¤‘
  - ë‚˜ë¨¸ì§€ëŠ” ì„ íƒì  ì°¸ì„
- **Active Listening**: ë°œí‘œ ì¤‘ í•µì‹¬ í¬ì¸íŠ¸ 3ê°œë§Œ ë©”ëª¨
- **Energy Management**: ì ì‹¬ í›„ ì˜¤í›„ ì„¸ì…˜ ì „ ì§§ì€ íœ´ì‹
- **Follow-upì´ í•µì‹¬**: í•™íšŒ ì¤‘ë³´ë‹¤ í•™íšŒ í›„ 3ì¼ì´ ë” ì¤‘ìš”

## Common Mistakes (í”¼í•˜ê¸°!)

âŒ ëª¨ë“  ì„¸ì…˜ ì°¸ì„í•˜ë ¤ë‹¤ ì§€ì¹¨
âŒ ë„¤íŠ¸ì›Œí‚¹ ì—†ì´ ë°œí‘œë§Œ ë“£ê¸°
âŒ Follow-up email ë¯¸ë°œì†¡
âŒ ì§ˆë¬¸ ì¤€ë¹„ ì—†ì´ ì°¸ì„
âŒ ëª…í•¨ì— ë©”ëª¨ ì•ˆ í•˜ê¸°

## Success Checklist

âœ… í•µì‹¬ ì„¸ì…˜ 3-4ê°œ ì„ ì •
âœ… ê° ì„¸ì…˜ ì§ˆë¬¸ 1-2ê°œ ì¤€ë¹„
âœ… ë„¤íŠ¸ì›Œí‚¹ íƒ€ê²Ÿ 5ëª… ì„ ì •
âœ… ë°œí‘œ ì§í›„ ì¦‰ì‹œ ëª…í•¨ êµí™˜
âœ… 3ì¼ ë‚´ follow-up email

---

**Good luck at MSK2025! ğŸš€**

*ì´ ê°€ì´ë“œëŠ” ì—°ìì™€ ë°œí‘œ ì œëª© ê¸°ë°˜ ì›¹ ê²€ìƒ‰ì„ í†µí•´ ì‘ì„±ë˜ì—ˆìœ¼ë©°,
ì‹¤ì œ ë°œí‘œ ë‚´ìš©ì€ ë‹¤ë¥¼ ìˆ˜ ìˆìŠµë‹ˆë‹¤. í•™íšŒ ë‹¹ì¼ í”„ë¡œê·¸ë¨ì„ ìµœì¢… í™•ì¸í•˜ì„¸ìš”.*
